{"nct_id":"NCT01154166","title":"A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa","status":"COMPLETED","status_verified_date":"2018-06","start_date":"2010-02-15","start_date_type":null,"primary_completion_date":"2011-09-01","primary_completion_date_type":"ACTUAL","completion_date":"2011-09-29","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}